Your browser doesn't support javascript.
loading
Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine.
Richmond, Peter C; Hatchuel, Lara; Pacciarini, Filippo; Hu, Branda; Smolenov, Igor; Li, Ping; Liang, Peng; Han, Htay Htay; Liang, Joshua; Clemens, Ralf.
Afiliação
  • Richmond PC; Division of Paediatrics, University of Western Australia, Perth, Australia.
  • Hatchuel L; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth Children's Hospital, Perth, Australia.
  • Pacciarini F; Linear Clinical Research, Nedlands, Australia.
  • Hu B; Clover Biopharmaceuticals, Chengdu, China.
  • Smolenov I; Clover Biopharmaceuticals, Chengdu, China.
  • Li P; Clover Biopharmaceuticals, Chengdu, China.
  • Liang P; Clover Biopharmaceuticals, Chengdu, China.
  • Han HH; Clover Biopharmaceuticals, Chengdu, China.
  • Liang J; Clover Biopharmaceuticals, Chengdu, China.
  • Clemens R; Clover Biopharmaceuticals, Chengdu, China.
J Infect Dis ; 224(10): 1699-1706, 2021 11 22.
Article em En | MEDLINE | ID: mdl-34480575
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Newborn Idioma: En Revista: J Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Newborn Idioma: En Revista: J Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália